Novel in vitro assay for the detection of pharmacologic inducers of fetal hemoglobin

Blood

Volumn 96, Issue 1, 2000, Pages 321-326

  Skarpidi, Evangelia ^a   Vassilopoulos, George ^a   Li, Qiliang ^a   Stamatoyannopoulos, George ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN F; LUCIFERASE;

ARTICLE; CELL LINE; ENZYME ASSAY; GENE ACTIVITY; GENE EXPRESSION; GENE INDUCTION; GENETIC ANALYSIS; GLOBIN GENE; IN VITRO STUDY; PRIORITY JOURNAL; REPORTER GENE;

EID: 0034235239     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.1.321.013k48_321_326     Document Type: Article

References (37)

1. Constantoulakis P, Knitter G, Stamatoyannopoulos G. On the induction of fetal hemoglobin by butyrates: in vivo and in vitro studies with sodium butyrate and comparison of combination treatment with 5-AzaC and AraC. Blood. 1989;74: 1963-1971.
2. Stamatoyannopoulos G, Blau CA, Nakamoto B, et al. Fetal hemoglobin induction by acetate, a product of butyrate catabolism. Blood 1994;84: 3198-3204.
3. Liakopoulou E, Blau CA, Li Q et al. Stimulation of fetal hemoglobin production by short chain fatty acids. Blood. 1995;86:3227-3235.
4. Torkelson S, White B, Faller DV, Phipps K, Pantazis C, Perrine S. Erythroid progenitor proliferation is stimulated by phenoxyacetic and phenyalkyl acids. Blood Cells Mol Dis. 1996;22:150-158.
5. Fibach E, Burke KP, Schechter AN, Noguchi CT, Rodgers GP. Hydroxyurea increases fetal hemoglobin in cultured erythroid cells derived from normal individuals and patients with sickle cell anemia or β-thalassemia. Blood. 1993;81:1630-1635.
6. Li Q, Blau CA, Clegg CH, Rhode A, Stamatoyannopoulos G. Multiple ∈ promoter elements participate in the developmental control of ∈ globin genes in transgenic mice. J Biol Chem. 1998;273: 17361-17367.
7. de Wet JR, Wood KV, Helinski DR, DeLuca M. Cloning of firefly luciferase cDNA and the expression of active luciferase in Escherichia coli. Proc Natl Acad Sci U S A. 1985;82:7870-7873.
8. Lorenz WW, Cormier MJ, O'Kane DJ, Hua D, Escher AA, Szalay AA. Expression of the renilla reniformis luciferase gene in mammalian cells. J Biolumin Chemilumin. 1996;11:31-37.
9. Aγ gene promoter mutants. Blood. 1996;88:1079-1083.
10. Peterson KR, Stamatoyannopoulos G. Role of gene order in developmental control of human γ-and β-globin gene expression. Mol Cell Biol. 1993;13:4836-4843.
11. Hanscombe O, Whyatt D, Fraser P, et al. Importance of globin gene order for correct developmental expression. Genes Dev. 1991;5:1387-1394.
12. Bunn FH. Sickle hemoglobin and other hemoglobin mutants. In: Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H, eds. The Molecular Basis of Blood Diseases. Philadelphia. PA: W.B. Saunders Company: 1994:207.
13. Weatherall DJ. The thalassemias. In: Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H, eds. The Molecular Basis of Blood Diseases, Philadelphia, PA: W.B. Saunders Company: 1994:157.
14. DeSimone J, Heller P, Hall L, Zwiers D. 5-Azacytidine stimulates fetal hemoglobin synthesis in anaemic baboons. Proc Natl Acad Sci U S A. 1982;79:4428-4431.
15. Ley TJ, DeSimone J, Anagnou NP, et al. 5-Azacytidine selectively increases γ-globin synthesis in patients with β+-thalassemia. N Engl J Med. 1982;307:1469-1475.
16. Torrealba de Ron AT, Papayannopoulou T, Knapp MS, Fu MF, Knitter G, Stamatoyannopoulos G. Perturbations in the erythroid marrow progenitor cell pools may play a role in the augmentation of HbF by 5-azacytidine. Blood. 1984;63:201-210.
17. Papayannopoulou T, Torrealba de Ron A, Veith R, Knitter G, Stamatoyannopoulos G. Arabinosylcytosine induces fetal hemoglobin in baboons by perturbing erythroid differentiation kinetics. Science. 1984;224:617-619.
18. Letvin NL, Linch DC, Beardsley GP, McIntyre KW, Nathan DG. Augmentation of fetal hemoglobin production in anemic monkeys by hydroxyurea. N Engl J Med. 1984;310:869-873.
19. Veith R, Papayannopoulou T, Kurachi S, Stamatoyannopoulos G. Treatment of baboon with vinblastine: insights into the mechanisms of pharmacologic stimulation of HbF in the adult. Blood. 1985;66:456-459.
20. Platt OS, Orkin SH, Dover G, Beardsley GP, Miller B, Nathan DG. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest. 1984;74:652-656.
21. Veith R, Galanello R, Papayannopoulou T, Stamatoyannopoulos G. Stimulation of F-cell production in patients with sickle cell anemia treated with cytarabine or hydroxyurea. N Engl J Med. 1985;313:1571-1575.
22. Rodgers GP, Dover GJ, Noguchi CT, Schechter AN, Nienhuis AW. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea. N Engl J Med. 1990;322:1037-1045.
23. Charache S, Dover GJ, Moore RD, et al. Hydroxyurea effects on hemoglobin F production in patients with sickle cell anemia. Blood. 1992;79: 2555-2565.
24. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia: Investigators of the Multicentric Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995;332:1317-1322.
25. Maier-Redelsperger M, Labie D, Elion J. Long-term hydroxyurea treatment in young sickle cell patients. Curr Opin Hematol. 1999;6:115-120.
26. Ginder GD, Whitters MJ, Pohlman JK. Activation of a chicken embryonic globin gene in adult erythroid cells by 5-azacytidine and sodium butyrate. Proc Natl Acad Sci U S A. 1984;81:3954-3958.
27. Perrine SP, Rudolph A, Faller DV, et al. Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching. Proc Natl Acad Sci U S A. 1988;85:8540-8542.
28. Constantoulakis P, Papayannopoulou T, Stamatoyannopoulos G. α-Amino-N-butyric acid stimulates fetal hemoglobin in the adult. Blood. 1988; 72:1961-1967.
29. Perrine SP, Miller BA, Faller DV, et al. Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with HbSS and β-thalassemia. Blood. 1989;74:454-459.
30. Perrine SP, Ginder GD, Faller DV, et al. A short term trial of butyrate to stimulate fetal-globin expression in the β-globin disorders. N Engl J Med. 1993;328:81-86.
31. Sher G, Ginder G, Little J, Yang S, Dover G, Olivieri N. Extended therapy with intravenous arginine butyrate in patients with β-hemoglobinopathies. N Engl J Med. 1995;332:1606-1610.
32. Dover GJ, Brusilow S, Samid D. Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate [letter]. N Engl J Med. 1992;327:569-570.
33. Galanello R, Cao A, Olivieri N. Induction of fetal hemoglobin in the presence of increased 3-hydroxybutyric acid associated with beta-ketothiolase deficiency. N Engl J Med. 1994;331:746-747.
34. Peters A, Rohloff D, Kohlmann T, et al. Fetal hemoglobin in starvation ketosis of young women. Blood. 1998;91:691-694.
35. Little JA, Dempsey NJ, Tuchman M, Ginder GD. Metabolic persistence of fetal hemoglobin. Blood. 1995;85:1712-1718.
36. Collins AF, Dover DJ, Luban NL. Increased fetal hemoglobin production in patients receiving valproic acid for epilepsy [letter]. Blood. 1994;84: 1690-1691.
37. Vassilopoulos G, Navas PA, Skarpidi E, et al. Correct function of the locus control region may require passage through a nonerythroid cellular environment. Blood. 1999;93:703-712.